April 12 (Reuters) - Resverlogix Corp RVX.TO :* HEALTH CANADA ISSUES RESVERLOGIX AUTHORIZATION TO BEGIN IMMEDIATE CLINICAL STUDIES OF APABETALONE FOR COVID-19* RESVERLOGIX CORP -...
March 12 (Reuters) - Resverlogix Corp RVX.TO :* RESVERLOGIX ANNOUNCES CHANGE IN FISCAL YEAR-END TO DECEMBER 31
Dec 22 (Reuters) - Resverlogix Corp RVX.TO :* RESVERLOGIX ANNOUNCES APABETALONE TREATMENT PRIOR TO SARS-COV-2 (COVID-19) EXPOSURE SIGNIFICANTLY REDUCES VIRAL INFECTION – CONFIRMS...
Canadian GDP released on TuesdayStatistics Canada will release the latest gross domestic product data for July on Tuesday morning.Canada’s real GDP for the second quarter,...
Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for disease states with high unmet medical needs. It is developing apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trial for patients with cardiovascular disease, diabetes mellitus, chronic kidney disease, end-stage renal disease, and neurodegenerative diseases. Resverlogix Corp. has a partnership with Eversana Life Science Services, LLC to support the pending launch of the commercialization of apabetalone for Covid-19 in the United States and Canada. The company is headquartered in Calgary, Canada.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 1.03 | 1.07 | 1.02 | 0.000 | 0.00% | 0.00 | TSXV | |||
| 16.79 | 16.79 | 16.78 | 0.000 | 0.00% | 0.00 | Toronto | |||
| 68.32 | 68.86 | 68.08 | -0.59 | -0.86% | 4.02M | Toronto | |||
| 0.76 | 0.77 | 0.76 | -0.02 | -2.56% | 21.57K | TSXV | |||
| 4.24 | 4.25 | 4.24 | 0.000 | 0.00% | 0.00 | Toronto | |||
| 12.30 | 12.30 | 12.28 | 0.00 | 0.00% | 0.00 | Toronto | |||
| 21.04 | 21.69 | 21.01 | -0.60 | -2.77% | 1.99M | Toronto | |||
| 0.04 | 0.05 | 0.04 | -0.01 | -11.11% | 47.82K | TSXV | |||
| 0.015 | 0.015 | 0.015 | +0.005 | +50.00% | 113.30K | TSXV | |||
| 32.99 | 34.24 | 32.50 | -1.42 | -4.13% | 77.41K | Toronto | |||
| 1.35 | 1.35 | 1.35 | 0.00 | 0.00% | 0.00 | NEO | |||
| 0.03 | 0.035 | 0.03 | -0.0100 | -25.00% | 25.33K | TSXV | |||
| 9.63 | 9.67 | 9.60 | 0.000 | 0.00% | 0.00 | Toronto | |||
| 0.01 | 0.01 | 0.01 | 0.0000 | 0.00% | 0.00 | TSXV | |||
| 71.30 | 73.24 | 70.21 | -1.34 | -1.84% | 1.12M | Toronto |